Procalcitonin Test Fails to Reduce Antibiotic Treatment Duration in Hospitalized Children
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Diagnostic Technologies, Sepsis |
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Melanie Hamilton-Basich | May 5, 2023 | Sepsis |
AACC has issued expert guidance on clinical testing for procalcitonin, a blood marker that helps detect serious bacterial infections and sepsis.
Read MorePosted by Steve Halasey | Jul 19, 2018 | Fertility Testing, Standards, Womens Health |
Validate PCT for Abbott Architect analyzers enables laboratories to document procalcitonin linearity and calibration verification.
Read MorePosted by Melissa Mayer | Jul 10, 2018 | Immunoassay, Infectious Diseases |
Monitoring procalcitonin levels assists with antibiotic stewardship and risk assessment of lower respiratory tract infections and sepsis.
Read MorePosted by Elaine Sanchez Wilson | Dec 12, 2017 | Immunoassay, Immunoassay Reagents & test Kits |
The Stanbio Chemistry Procalcitonin LiquiColor assay from EKF Diagnostics has received FDA premarket notification (510(k)) clearance and is validated for use on Beckman AU 480, 680, and 5800 clinical chemistry analyzers from Beckman Coulter.
Read More